Over the past 3 months, 6 analysts have published their opinion on HealthEquity (NASDAQ:HQY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company’s business to predict how a stock will trade over the upcoming year.HealthEquity, Inc. (NASDAQ:HQY – Get Rating) EVP Delano Ladd sold 5,897 shares of HealthEquity stock in a transaction on Friday, October 21st. The shares were sold at an average price of $75.00, for a total transaction of $442,275.00. Following the completion of the sale, the executive vice president now directly owns 37,471 shares of the company’s stock, valued at approximately $2,810,325. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.HealthEquity, Inc. (NASDAQ:HQY – Get Rating) has received a consensus rating of “Moderate Buy” from the sixteen research firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, one has assigned a hold rating and ten.

HealthEquity, Inc. (NASDAQ:HQY – Get Rating) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 3,990,000 shares, an increase of 10.2% from the August 31st total of 3,620,000 shares. Based on an average trading volume of 741,800 shares, the days-to-cover ratio is currently 5.4 days. Approximately 4.8% of the shares of the company are sold short.HealthEquity, Inc. (NASDAQ:HQY – Get Rating) EVP Larry L. Trittschuh sold 11,526 shares of the company’s stock in a transaction that occurred on Thursday, October 13th. The stock was sold at an average price of $70.00, for a total value of $806,820.00. Following the completion of the sale, the executive vice president now owns 27,961 shares in the company, valued at approximately $1,957,270. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.U.S. News & World Report — known for its healthcare rankings, including those that compare hospitals and physicians — has formulated a way to measure hospitals’ health equity. And it may eventually be included in the publication’s ranking methodology. . Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

. In this article, we discuss top 10 healthcare stocks to buy. If you want to read about some more healthcare stocks, go directly to Top 5 Healthcare Stocks to Buy. Focus in the healthcare sector has steadily been shifting away from the coronavirus pandemic to diversification, vertical integration, and new business building in the past. . .

Industry analysts also expect EPS at seven of the 11 largest U.S. managed care companies to climb year over year in the third quarter. Friday’s top analyst upgrades and downgrades included AT&T, Exxon Mobil, Hasbro, Juniper Networks, Moderna, Palo Alto Networks, Snap, Teva Pharmaceutical, Under Armour and Zscaler.HCA Healthcare, Inc.(NYSE:HCA): The healthcare industry is well known for its ability to ride out challenging economic conditions thanks to the inelastic demand for medical products and services. Given the current uncertain economic backdrop, it could be wise to invest in fundamentally sound medical stocks HCA Healthcare (HCA), Fresenius SE & Co. (FSNUY), and Hanger (HNGR) ahead of the fourth quarter. However, not all medical stocks are fit to survive the turbulent market conditions. So, it could be wise to avoid Cano Health (CANO), considering its weak fundamentals and growth prospects. Let’s discuss.

. Humana Inc.(NYSE:HUM): Given the inelastic demand for healthcare products and services, the sector should remain resilient amid uncertain economic conditions. Therefore, Humana (HUM) and HealthEquity (HQY) should stay afloat. But which of these stocks is a better choice for investors? Read more to find out. A high-level overview of HealthEquity, Inc. (HQY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Morningstar’s Sixth Annual Health Savings Account Landscape Finds Fidelity Remains Industry Leader

/PRNewswire/ — Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, today published its sixth annual landscape study on. $100,000 donation will support National Association for Free and Charitable Clinics programming and health equity scholarship opportunities
Donation advances the Owens & Minor Foundation’s. | October 29, 2022. . ST. LOUIS, March 21, 2022  /PRNewswire/ — Centene Corporation (NYSE: CNC) (“Centene”) announced today it has been awarded the Innovation Award for Health Equity by the National Committee for Quality Assurance.

.